Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Oligonucleotide Synthesis Services Market Value Growth And Long-Term Outlook
The oligonucleotide synthesis services market has seen strong growth in recent times. It is anticipated to expand from $2.93 billion in 2025 to $3.21 billion in 2026, at a compound annual growth rate (CAGR) of 9.7%. This historical growth can be linked to the increased adoption of PCR and sequencing, the broadening of molecular biology research, a surge in genomic testing, enhanced academic genomics funding, and intensified biotech research and development efforts.
The oligonucleotide synthesis services market is anticipated to demonstrate robust growth over the next few years. It is projected to reach $4.7 billion in 2030, achieving a compound annual growth rate (CAGR) of 10.0%. This growth during the forecast period can be attributed to the expansion of gene and cell therapy pipelines, increasing demand for CRISPR and gene editing, the proliferation of nucleic acid therapeutics, enhanced use of precision diagnostics, and the scaling up of clinical oligo production. Major trends influencing the forecast period include high-throughput custom oligo production, specialized modified and labeled oligonucleotide services, GMP-grade oligo manufacturing, rapid turnaround gene editing oligos, and advanced oligo purification workflows.
Get A Free Sample Report With In-Depth Market Insights:
Oligonucleotide Synthesis Services Market Growth Catalysts And Demand Drivers
The rising emphasis on personalized medicine is anticipated to fuel the expansion of the oligonucleotide synthesis services market in the future. Personalized medicine, which tailors treatment and prevention strategies to an individual’s unique genetic, biological, and lifestyle traits, is seeing increased adoption owing to advancements in genomics and molecular diagnostics that enable customized treatments for improved outcomes. Oligonucleotide synthesis services support this by facilitating the swift and accurate creation of specific DNA or RNA sequences vital for patient-specific diagnostics, targeted therapies, and gene-based treatments, thereby allowing interventions aligned with an individual’s genetic makeup. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA sanctioned 16 new personalized treatments for rare disease patients, an increase from six in 2022. These approvals for 2023 also encompassed seven cancer drugs and three for other diseases and conditions. Consequently, the growing focus on personalized medicine is propelling the growth of the oligonucleotide synthesis services market.
Oligonucleotide Synthesis Services Market Segment Outlook: Which Categories Are Growing Fastest?
The oligonucleotide synthesis services market covered in this report is segmented –
1) By Type Of Oligonucleotide: Deoxyribonucleic Acid Oligonucleotides; Ribonucleic Acid Oligonucleotides; Peptide Nucleic Acids (PNAs); Locked Nucleic Acids (LNAs); Other Synthetic Nucleotides
2) By Synthesis Method: Solid Phase Synthesis; Liquid Phase Synthesis; Microarray Based Synthesis; Oligonucleotide Synthesis Via Automated Synthesizers; Enzymatic Synthesis
3) By Purity Level: Standard Purity; High Purity; Ultra High Purity; Custom Purity Solutions; Quality Control Measures
4) By Application: Diagnostics; Therapeutics; Research And Development; Gene Editing; Vaccine Development
5) By End User: Academic And Research Institutions; Pharmaceutical And Biotechnology Companies; Diagnostic Laboratories; Contract Research Organizations (CROs); Clinical Laboratories
Subsegments:
1) By Deoxyribonucleic Acid Oligonucleotides: Standard Deoxyribonucleic Acid Oligonucleotides; Modified Deoxyribonucleic Acid Oligonucleotides; Phosphorothioate Deoxyribonucleic Acid Oligonucleotides; Methylated Deoxyribonucleic Acid Oligonucleotides
2) By Ribonucleic Acid Oligonucleotides: Standard Ribonucleic Acid Oligonucleotides; Modified Ribonucleic Acid Oligonucleotides; Small Interfering Ribonucleic Acid Oligonucleotides; Micro Ribonucleic Acid Oligonucleotides
3) By Peptide Nucleic Acids: Standard Peptide Nucleic Acids; Modified Peptide Nucleic Acids; Functionalized Peptide Nucleic Acids
4) By Locked Nucleic Acids: Standard Locked Nucleic Acids; 2′-O-Methyl Locked Nucleic Acids; Gapmer Locked Nucleic Acids
5) By Other Synthetic Nucleotides: Morpholino Oligonucleotides; Phosphoramidite Oligonucleotides; Xeno Nucleic Acid Oligonucleotides; Synthetic Aptamers
Oligonucleotide Synthesis Services Market Trends Shaping Long-Term Demand
Leading companies in the oligonucleotide synthesis services market are directing their efforts towards expanding DNA and RNA production capabilities to facilitate therapeutic and diagnostic research. These DNA and RNA production capabilities utilize advanced methodologies for generating and scaling high-quality genetic material, which are pivotal in supporting research, diagnostics, and the development of biopharmaceutical treatments. For example, in May 2025, Oligo Factory Inc., a US-based manufacturing company, introduced a low-scale oligo synthesis capability to extend its support to therapeutic and diagnostic researchers and developers. This new offering allows for small-batch custom DNA/RNA production, starting at 50 nmol, serving early research and development stages in areas such as therapeutics, diagnostics, qPCR, NGS, and preclinical studies. It aims to decrease costs and waste, provide swift turnaround times (4 weeks or less) with GMP or ISO 13485 quality, and enable smooth scaling without requiring vendor changes, through portfolios like FactorTx. This flexibility is particularly beneficial for researchers who require prototypes rather than large minimum order quantities.
Oligonucleotide Synthesis Services Market Company Landscape And Competitive Strategy
Major companies operating in the oligonucleotide synthesis services market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., QIAGEN N.V., Integrated DNA Technologies Inc., Sangon Biotech (Shanghai) Co. Ltd., Ajinomoto Co. Inc., Twist Bioscience Corporation, Sigma-Aldrich Co. LLC, Aldevron LLC, Bioneer Corporation, GenScript Biotech Corporation, BBI Life Sciences Ltd., Takara Bio Inc., BioServe Biotechnologies Ltd., Eurofins Genomics Germany GmbH, Bio-Synthesis Inc., TriLink BioTechnologies LLC, BioBasic Inc., Biosearch Technologies Inc., JenaBioscience GmbH, Geneworks Pty Ltd., HUWEL Life Science Co. Ltd., and SynoLigo Pvt. Ltd.
View The Full Oligonucleotide Synthesis Services Market Report:
Oligonucleotide Synthesis Services Market Largest Region: Which Geography Holds The Highest Market Share?
North America was the largest region in the oligonucleotide synthesis services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oligonucleotide synthesis services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model